Annual CFI
$651.00 K
+$27.15 M+102.46%
31 December 2023
Summary:
Oncternal Therapeutics annual cash flow from investing activities is currently $651.00 thousand, with the most recent change of +$27.15 million (+102.46%) on 31 December 2023. ONCT annual CFI is now -97.67% below its all-time high of $27.88 million, reached on 31 December 2018.ONCT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$13.65 M
+$7.84 M+135.02%
30 September 2024
Summary:
Oncternal Therapeutics quarterly cash flow from investing activities is currently $13.65 million, with the most recent change of +$7.84 million (+135.02%) on 30 September 2024. Over the past year, it has increased by +$8.99 million (+193.23%). ONCT quarterly CFI is now -29.60% below its all-time high of $19.39 million, reached on 31 December 2012.ONCT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$24.87 M
+$8.99 M+56.65%
30 September 2024
Summary:
Oncternal Therapeutics TTM cash flow from investing activities is currently $24.87 million, with the most recent change of +$8.99 million (+56.65%) on 30 September 2024. Over the past year, it has increased by +$48.91 million (+203.47%). ONCT TTM CFI is now -46.79% below its all-time high of $46.75 million, reached on 30 June 2019.ONCT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +102.5% | +193.2% | +203.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | -97.7% | +951.0% | -19.6% |
ONCT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +102.5% | -1.5% | +151.5% | at high | +158.5% |
| 5 y | 5 years | -97.7% | +102.5% | -1.5% | +151.5% | -19.6% | +158.5% |
| alltime | all time | -97.7% | +102.1% | -29.6% | +146.3% | -46.8% | +158.5% |
Oncternal Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.65 M(+135.0%) | $24.87 M(+56.6%) |
| June 2024 | - | $5.81 M(-19.6%) | $15.88 M(-33.6%) |
| Mar 2024 | - | $7.22 M(-499.6%) | $23.92 M(+3574.8%) |
| Dec 2023 | $651.00 K(-102.5%) | -$1.81 M(-138.8%) | $651.00 K(-102.7%) |
| Sept 2023 | - | $4.66 M(-66.4%) | -$24.04 M(-16.2%) |
| June 2023 | - | $13.85 M(-186.3%) | -$28.69 M(-32.6%) |
| Mar 2023 | - | -$16.05 M(-39.4%) | -$42.55 M(+60.6%) |
| Dec 2022 | -$26.50 M(<-9900.0%) | -$26.50 M(<-9900.0%) | -$26.50 M(<-9900.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | $0.00(-100.0%) | - | - |
| Mar 2020 | - | $0.00(0.0%) | $16.11 M(-0.2%) |
| Dec 2019 | $16.14 M(-42.1%) | $0.00(-100.0%) | $16.14 M(-47.8%) |
| Sept 2019 | - | -$1.60 M(-109.1%) | $30.92 M(-33.9%) |
| June 2019 | - | $17.72 M(>+9900.0%) | $46.75 M(+174.8%) |
| Mar 2019 | - | $25.00 K(-99.8%) | $17.01 M(-39.0%) |
| Dec 2018 | $27.88 M(-284.3%) | $14.78 M(+4.0%) | $27.88 M(-288.6%) |
| Sept 2018 | - | $14.22 M(-218.3%) | -$14.79 M(-35.7%) |
| June 2018 | - | -$12.02 M(-210.3%) | -$23.01 M(+172.3%) |
| Mar 2018 | - | $10.90 M(-139.1%) | -$8.45 M(-44.1%) |
| Dec 2017 | -$15.13 M(-803.2%) | -$27.89 M(-564.8%) | -$15.13 M(-402.5%) |
| Sept 2017 | - | $6.00 M(+136.2%) | $5.00 M(+27.6%) |
| June 2017 | - | $2.54 M(-39.8%) | $3.92 M(+16.0%) |
| Mar 2017 | - | $4.22 M(-154.4%) | $3.38 M(+57.0%) |
| Dec 2016 | $2.15 M(-86.7%) | -$7.76 M(-257.8%) | $2.15 M(-87.6%) |
| Sept 2016 | - | $4.92 M(+145.9%) | $17.37 M(+16.6%) |
| June 2016 | - | $2.00 M(-33.2%) | $14.90 M(-18.2%) |
| Mar 2016 | - | $2.99 M(-59.9%) | $18.23 M(+12.4%) |
| Dec 2015 | $16.21 M(-151.9%) | $7.46 M(+204.9%) | $16.21 M(-178.1%) |
| Sept 2015 | - | $2.45 M(-54.0%) | -$20.75 M(+9.0%) |
| June 2015 | - | $5.32 M(+444.2%) | -$19.04 M(-24.1%) |
| Mar 2015 | - | $978.00 K(-103.3%) | -$25.09 M(-19.6%) |
| Dec 2014 | -$31.22 M(-438.0%) | -$29.50 M(-808.5%) | -$31.22 M(-2748.0%) |
| Sept 2014 | - | $4.16 M(-666.5%) | $1.18 M(-192.8%) |
| June 2014 | - | -$735.00 K(-85.7%) | -$1.27 M(-158.9%) |
| Mar 2014 | - | -$5.15 M(-277.6%) | $2.16 M(-76.6%) |
| Dec 2013 | $9.24 M(-56.8%) | $2.90 M(+69.0%) | $9.24 M(-64.1%) |
| Sept 2013 | - | $1.72 M(-36.3%) | $25.73 M(+7.1%) |
| June 2013 | - | $2.69 M(+39.4%) | $24.03 M(+16.2%) |
| Mar 2013 | - | $1.93 M(-90.0%) | $20.69 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $21.41 M(-307.8%) | $19.39 M(>+9900.0%) | $21.41 M(+1986.3%) |
| Sept 2012 | - | $16.00 K(-102.5%) | $1.03 M(-686.3%) |
| June 2012 | - | -$651.00 K(-124.6%) | -$175.00 K(-88.4%) |
| Mar 2012 | - | $2.65 M(-367.9%) | -$1.51 M(-85.4%) |
| Dec 2011 | -$10.30 M(-224.4%) | -$989.00 K(-16.5%) | -$10.30 M(+35.5%) |
| Sept 2011 | - | -$1.19 M(-40.3%) | -$7.60 M(+3502.8%) |
| June 2011 | - | -$1.98 M(-67.7%) | -$211.00 K(-108.4%) |
| Mar 2011 | - | -$6.14 M(-459.5%) | $2.51 M(-69.7%) |
| Dec 2010 | $8.28 M(-187.9%) | $1.71 M(-72.5%) | $8.28 M(+46.4%) |
| Sept 2010 | - | $6.21 M(+746.7%) | $5.65 M(-164.2%) |
| June 2010 | - | $733.00 K(-299.7%) | -$8.81 M(-9.2%) |
| Mar 2010 | - | -$367.00 K(-60.0%) | -$9.70 M(+2.9%) |
| Dec 2009 | -$9.43 M(+224.4%) | -$918.00 K(-88.9%) | -$9.43 M(+8.3%) |
| Sept 2009 | - | -$8.26 M(+5228.4%) | -$8.70 M(+777.8%) |
| June 2009 | - | -$155.00 K(+66.7%) | -$991.00 K(-56.9%) |
| Mar 2009 | - | -$93.00 K(-51.6%) | -$2.30 M(-20.8%) |
| Dec 2008 | -$2.90 M(+67.3%) | -$192.00 K(-65.2%) | -$2.90 M(-18.2%) |
| Sept 2008 | - | -$551.00 K(-62.4%) | -$3.55 M(+7.0%) |
| June 2008 | - | -$1.47 M(+110.2%) | -$3.32 M(+46.0%) |
| Mar 2008 | - | -$697.00 K(-17.0%) | -$2.28 M(+31.1%) |
| Dec 2007 | -$1.74 M(+200.3%) | -$840.00 K(+162.5%) | -$1.74 M(+81.2%) |
| Sept 2007 | - | -$320.00 K(-23.6%) | -$958.00 K(+19.3%) |
| June 2007 | - | -$419.00 K(+166.9%) | -$803.00 K(+80.0%) |
| Mar 2007 | - | -$157.00 K(+153.2%) | -$446.00 K(-22.8%) |
| Dec 2006 | -$578.00 K(-58.1%) | -$62.00 K(-62.4%) | -$578.00 K(-20.4%) |
| Sept 2006 | - | -$165.00 K(+166.1%) | -$726.00 K(-15.0%) |
| June 2006 | - | -$62.00 K(-78.5%) | -$854.00 K(-40.4%) |
| Mar 2006 | - | -$289.00 K(+37.6%) | -$1.43 M(+3.7%) |
| Dec 2005 | -$1.38 M(-77.0%) | -$210.00 K(-28.3%) | -$1.38 M(-77.5%) |
| Sept 2005 | - | -$293.00 K(-54.2%) | -$6.14 M(+1.3%) |
| June 2005 | - | -$640.00 K(+168.9%) | -$6.07 M(-1.6%) |
| Mar 2005 | - | -$238.00 K(-95.2%) | -$6.17 M(+2.8%) |
| Dec 2004 | -$6.00 M(+5455.6%) | -$4.97 M(+2201.9%) | -$6.00 M(+457.6%) |
| Sept 2004 | - | -$216.00 K(-70.9%) | -$1.08 M(+22.1%) |
| June 2004 | - | -$741.00 K(+943.7%) | -$881.00 K(+400.6%) |
| Mar 2004 | - | -$71.00 K(+47.9%) | -$176.00 K(+63.0%) |
| Dec 2003 | -$108.00 K(-65.5%) | -$48.00 K(+128.6%) | -$108.00 K(+80.0%) |
| Sept 2003 | - | -$21.00 K(-41.7%) | -$60.00 K(+53.8%) |
| June 2003 | - | -$36.00 K(+1100.0%) | -$39.00 K(+1200.0%) |
| Mar 2003 | - | -$3000.00 | -$3000.00 |
| Dec 2002 | -$313.00 K | - | - |
FAQ
- What is Oncternal Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual CFI year-on-year change?
- What is Oncternal Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly CFI year-on-year change?
- What is Oncternal Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Oncternal Therapeutics?
- What is Oncternal Therapeutics TTM CFI year-on-year change?
What is Oncternal Therapeutics annual cash flow from investing activities?
The current annual CFI of ONCT is $651.00 K
What is the all time high annual CFI for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual cash flow from investing activities is $27.88 M
What is Oncternal Therapeutics annual CFI year-on-year change?
Over the past year, ONCT annual cash flow from investing activities has changed by +$27.15 M (+102.46%)
What is Oncternal Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ONCT is $13.65 M
What is the all time high quarterly CFI for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly cash flow from investing activities is $19.39 M
What is Oncternal Therapeutics quarterly CFI year-on-year change?
Over the past year, ONCT quarterly cash flow from investing activities has changed by +$8.99 M (+193.23%)
What is Oncternal Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ONCT is $24.87 M
What is the all time high TTM CFI for Oncternal Therapeutics?
Oncternal Therapeutics all-time high TTM cash flow from investing activities is $46.75 M
What is Oncternal Therapeutics TTM CFI year-on-year change?
Over the past year, ONCT TTM cash flow from investing activities has changed by +$48.91 M (+203.47%)